BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 14609948)

  • 1. Sphingolipids are essential for differentiation but not growth in Leishmania.
    Zhang K; Showalter M; Revollo J; Hsu FF; Turk J; Beverley SM
    EMBO J; 2003 Nov; 22(22):6016-26. PubMed ID: 14609948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipid-free Leishmania are defective in membrane trafficking, differentiation and infectivity.
    Denny PW; Goulding D; Ferguson MA; Smith DF
    Mol Microbiol; 2004 Apr; 52(2):313-27. PubMed ID: 15066023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in Leishmania.
    Zhang K; Pompey JM; Hsu FF; Key P; Bandhuvula P; Saba JD; Turk J; Beverley SM
    EMBO J; 2007 Feb; 26(4):1094-104. PubMed ID: 17290222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania salvage and remodelling of host sphingolipids in amastigote survival and acidocalcisome biogenesis.
    Zhang K; Hsu FF; Scott DA; Docampo R; Turk J; Beverley SM
    Mol Microbiol; 2005 Mar; 55(5):1566-78. PubMed ID: 15720561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmentally regulated sphingolipid degradation in Leishmania major.
    Zhang O; Xu W; Balakrishna Pillai A; Zhang K
    PLoS One; 2012; 7(1):e31059. PubMed ID: 22299050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol phosphorylceramide synthase null Leishmania are viable and virulent in animal infections where salvage of host sphingomyelin predominates.
    Kuhlmann FM; Key PN; Hickerson SM; Turk J; Hsu FF; Beverley SM
    J Biol Chem; 2022 Nov; 298(11):102522. PubMed ID: 36162499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipid synthesis is necessary for kinetoplast segregation and cytokinesis in Trypanosoma brucei.
    Fridberg A; Olson CL; Nakayasu ES; Tyler KM; Almeida IC; Engman DM
    J Cell Sci; 2008 Feb; 121(Pt 4):522-35. PubMed ID: 18230649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myriocin, a serine palmitoyltransferase inhibitor, blocks cytokinesis in Leishmania (Viannia) braziliensis promastigotes.
    Castro EV; Yoneyama KG; Haapalainen EF; Toledo MS; Takahashi HK; Straus AH
    J Eukaryot Microbiol; 2013; 60(4):377-87. PubMed ID: 23659342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rafts and sphingolipid biosynthesis in the kinetoplastid parasitic protozoa.
    Denny PW; Smith DF
    Mol Microbiol; 2004 Aug; 53(3):725-33. PubMed ID: 15255887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of host sphingomyelin is essential for Leishmania virulence.
    Zhang O; Wilson MC; Xu W; Hsu FF; Turk J; Kuhlmann FM; Wang Y; Soong L; Key P; Beverley SM; Zhang K
    PLoS Pathog; 2009 Dec; 5(12):e1000692. PubMed ID: 20011126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin.
    Cunningham ML; Titus RG; Turco SJ; Beverley SM
    Science; 2001 Apr; 292(5515):285-7. PubMed ID: 11303103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipid degradation by Leishmania major is required for its resistance to acidic pH in the mammalian host.
    Xu W; Xin L; Soong L; Zhang K
    Infect Immun; 2011 Aug; 79(8):3377-87. PubMed ID: 21576322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymes of sphingolipid metabolism in Drosophila melanogaster.
    Acharya U; Acharya JK
    Cell Mol Life Sci; 2005 Jan; 62(2):128-42. PubMed ID: 15666085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine endothelial serine palmitoyltransferase 1 (SPTLC1) is required for vascular development and systemic sphingolipid homeostasis.
    Kuo A; Checa A; Niaudet C; Jung B; Fu Z; Wheelock CE; Singh SA; Aikawa M; Smith LE; Proia RL; Hla T
    Elife; 2022 Oct; 11():. PubMed ID: 36197001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels.
    Johnson EL; Heaver SL; Waters JL; Kim BI; Bretin A; Goodman AL; Gewirtz AT; Worgall TS; Ley RE
    Nat Commun; 2020 May; 11(1):2471. PubMed ID: 32424203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a compensatory mutant of Leishmania major that lacks ether lipids but exhibits normal growth, and G418 and hygromycin resistance.
    Zufferey R; Bibis SS; Zhu T; Dhalladoo S
    Exp Parasitol; 2012 Mar; 130(3):200-4. PubMed ID: 22306069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipids in parasitic protozoa.
    Zhang K; Bangs JD; Beverley SM
    Adv Exp Med Biol; 2010; 688():238-48. PubMed ID: 20919659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid and sphingolipid metabolism in Leishmania.
    Zhang K; Beverley SM
    Mol Biochem Parasitol; 2010 Apr; 170(2):55-64. PubMed ID: 20026359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation.
    Späth GF; Beverley SM
    Exp Parasitol; 2001 Oct; 99(2):97-103. PubMed ID: 11748963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis.
    Mina JGM; Denny PW
    Parasitology; 2018 Feb; 145(2):134-147. PubMed ID: 28637533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.